JP2011514901A5 - - Google Patents

Download PDF

Info

Publication number
JP2011514901A5
JP2011514901A5 JP2010549663A JP2010549663A JP2011514901A5 JP 2011514901 A5 JP2011514901 A5 JP 2011514901A5 JP 2010549663 A JP2010549663 A JP 2010549663A JP 2010549663 A JP2010549663 A JP 2010549663A JP 2011514901 A5 JP2011514901 A5 JP 2011514901A5
Authority
JP
Japan
Prior art keywords
gene
pharmaceutical composition
stem cells
composition according
mesenchymal stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010549663A
Other languages
English (en)
Japanese (ja)
Other versions
JP6037597B2 (ja
JP2011514901A (ja
Filing date
Publication date
Priority claimed from US12/042,487 external-priority patent/US20080286249A1/en
Application filed filed Critical
Publication of JP2011514901A publication Critical patent/JP2011514901A/ja
Publication of JP2011514901A5 publication Critical patent/JP2011514901A5/ja
Application granted granted Critical
Publication of JP6037597B2 publication Critical patent/JP6037597B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010549663A 2008-03-05 2009-03-04 遺伝子疾患および障害を治療するための間葉系幹細胞の使用 Expired - Fee Related JP6037597B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/042,487 2008-03-05
US12/042,487 US20080286249A1 (en) 2006-01-12 2008-03-05 Use of mesenchymal stem cells for treating genetic diseases and disorders
PCT/US2009/001390 WO2009111030A1 (en) 2008-03-05 2009-03-04 Use of mesenchymal stem cells for treating genetic diseases and disorders

Publications (3)

Publication Number Publication Date
JP2011514901A JP2011514901A (ja) 2011-05-12
JP2011514901A5 true JP2011514901A5 (https=) 2012-04-19
JP6037597B2 JP6037597B2 (ja) 2016-12-07

Family

ID=40635808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549663A Expired - Fee Related JP6037597B2 (ja) 2008-03-05 2009-03-04 遺伝子疾患および障害を治療するための間葉系幹細胞の使用

Country Status (10)

Country Link
US (8) US20080286249A1 (https=)
EP (1) EP2262513A1 (https=)
JP (1) JP6037597B2 (https=)
CN (1) CN102014936A (https=)
AU (1) AU2009220137A1 (https=)
BR (1) BRPI0909817A2 (https=)
CA (1) CA2717498A1 (https=)
MX (1) MX2010009767A (https=)
NZ (1) NZ587809A (https=)
WO (1) WO2009111030A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2471904T (pt) 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
KR20240052847A (ko) 2008-08-20 2024-04-23 셀룰래리티 인코포레이티드 개선된 세포 조성물 및 그의 제조 방법
CA2734446C (en) 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
CN105708862B (zh) 2008-09-02 2020-11-06 普拉里斯坦有限公司 来自胎盘组织的粘附细胞及其在治疗中的用途
AU2009316541B2 (en) 2008-11-19 2015-08-06 Celularity Inc. Amnion derived adherent cells
PH12012500892A1 (en) * 2009-11-27 2016-09-09 Stempeutics Res Pvt Ltd Methods of preparing mesenchymal stem cells, compositions and kit thereof
US20110142805A1 (en) * 2009-12-15 2011-06-16 Advanced Technologies And Regenerative Medicine, Llc Method of renal repair and regeneration and the treatment of diabetic nephropathy
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
EP3260533B1 (en) 2011-03-22 2019-09-11 Pluristem Ltd. Methods for treating radiation or chemical injury
JP6104896B2 (ja) 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療
WO2013055476A1 (en) * 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
CN103183736A (zh) * 2011-12-27 2013-07-03 北京和信非凡生物技术有限公司 一种抗clcn7蛋白的单克隆抗体及其应用
WO2014039429A1 (en) * 2012-09-04 2014-03-13 Anthrogenesis Corporation Methods of tissue generation
WO2014087658A1 (en) * 2012-12-07 2014-06-12 Kuraray Co., Ltd. Method of cell fusion and fusion cells
CN104042606B (zh) * 2013-03-12 2017-05-24 国钦生物科技股份有限公司 苯酞化合物的应用
US20140271568A1 (en) 2013-03-12 2014-09-18 Hawking Biological Technology Co., Ltd Method and kit for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, cxc chemokine receptor 4, and/or immune regulatory factor of stem cell
JP6683628B2 (ja) * 2014-06-04 2020-04-22 シーダーズ−サイナイ メディカル センター 脊椎圧迫骨折の非外科的修復のための方法
CN104726496B (zh) * 2015-03-27 2017-07-07 中国科学院生物物理研究所 携带人类成年早衰症基因突变的多能干细胞及制备方法
CA2988137C (en) * 2015-06-11 2021-01-26 Maria Siemionow Muscular dystrophy chimeric cells and method for treating muscular dystrophies
US11253630B2 (en) 2016-04-22 2022-02-22 Vivex Biologics Group, Inc. Malleable demineralized bone composition and method of manufacture
US9788950B1 (en) 2016-04-22 2017-10-17 Vivex Biomedical, Inc. Cohesive bone composition
US11253629B2 (en) 2016-04-22 2022-02-22 Vivex Biologics Group, Inc. Bone gel sheet composition and method of manufacture
US10596298B2 (en) 2016-04-22 2020-03-24 Vivex Biologics Group, Inc. Malleable demineralized bone composition and method of manufacture
US10463767B2 (en) 2016-04-22 2019-11-05 Vivex Biologics Group, Inc. Moldable bone composition
JP7105195B2 (ja) 2016-11-15 2022-07-22 株式会社カネカ 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
PL3717635T3 (pl) * 2017-11-28 2026-02-16 The Board Of Trustees Of The University Of Illinois Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych
EP3750987A4 (en) 2017-12-28 2021-11-10 Kaneka Corporation CELL POPULATION INCLUDING ADHESIVE STEM CELLS, ITS PRODUCTION PROCESS, AND PHARMACEUTICAL COMPOSITION
EP3984596A4 (en) 2019-06-14 2023-06-21 Kaneka Corporation POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF
EP4677077A1 (en) * 2023-03-06 2026-01-14 Lingyi Biotech Co., Ltd. A truncated atp7b and the use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5635156A (en) * 1993-09-13 1997-06-03 University Of Pittsburgh Non-lethal methods for conditioning a recipient for bone marrow transplantation
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US6974571B2 (en) * 1995-03-28 2005-12-13 Thomas Jefferson University Isolated stromal cells and methods of using the same
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
AU749675B2 (en) * 1998-03-13 2002-07-04 Mesoblast International Sarl Uses for human non-autologous mesenchymal stem cells
US6328960B1 (en) * 1998-03-18 2001-12-11 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US7544509B2 (en) * 2000-01-24 2009-06-09 Mcgill University Method for preparing stem cell preparations
US20040235160A1 (en) * 2001-08-07 2004-11-25 Mitsuo Nishikawa Process for preparing hematopoietic stem cells
US7666675B2 (en) * 2001-09-20 2010-02-23 Anticancer, Inc. Nestin-expressing hair follicle stem cells
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US20030157110A1 (en) * 2002-01-07 2003-08-21 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
CA2476999C (en) * 2002-02-22 2015-09-15 Intracel Resources Llc Sterile immunogenic non-tumorigenic tumor cell compositions and methods
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
DE10242337A1 (de) * 2002-09-09 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antikörper zur Isolierung und/oder Identifizierung neuronaler Stammzellen und Verfahren zur Isolierung und/oder Identifizierung neuronaler Vorläuferzellen
GB0304030D0 (en) * 2003-02-21 2003-03-26 King S College London Teeth
AU2004242091C1 (en) * 2003-05-07 2009-12-24 La Jolla Institute For Molecular Medicine Administration of hyaluronic acid to enhance the function of transplanted stem cells
WO2005010524A1 (en) * 2003-06-04 2005-02-03 Curis, Inc. Stem cell-based methods for identifying and characterizing agents
WO2005001080A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US20050256077A1 (en) * 2004-03-30 2005-11-17 Henning Susan J Gastrointestinal stem cells and uses thereof
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders

Similar Documents

Publication Publication Date Title
JP2011514901A5 (https=)
IL212368A (en) Compounds that increase the spread of hematopoietic stem cells, in vitro methods to increase the number of stem and progenitor cells, a population of cells containing striated hematopoietic stem cells, preparations containing it, and the use of said cells in drug production.
WO2011130624A3 (en) Sustained polypeptide expression from synthetic, modified rnas and uses thereof
MX358744B (es) Composiciones y métodos para la producción y administración de ácido ribonucleico.
GB0916370D0 (en) Compositions
PH12018500371A1 (en) Clinical formulations
GB2472964A (en) Vectors for delivery of light-sensitive proteins and methods of use
GB2469251A (en) Shear reactor for vortex synthesis of nanotubes
NZ587809A (en) Use of mesenchymal stem cells expressing cd73 and/or cd105 for treating genetic diseases and disorders
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
JP2013027385A5 (https=)
BR112012013664A2 (pt) rabdovírus oncolítico
JP2013530680A5 (https=)
WO2012048010A3 (en) Compositions of adult organ stem cells and uses thereof
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
JP2016500260A5 (https=)
WO2011163531A3 (en) Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
Chowdhury et al. Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence
MX387420B (es) Producción de virus en cultivos celulares.
JP2010504339A5 (https=)
Zhao et al. A mesenchymal stem cell aging framework, from mechanisms to strategies
JP2010053122A5 (https=)
Deng et al. MicroRNA replacing oncogenic Klf4 and c-Myc for generating iPS cells via cationized pleurotus eryngii polysaccharide-based nanotransfection
JP2016510766A5 (https=)
Li et al. Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation